Tue, July 14, 2020
Mon, July 13, 2020
Fri, July 10, 2020

Geoff Meacham Reiterated (BTAI) at Strong Buy with Increased Target to $63 on, Jul 13th, 2020

Geoff Meacham of B of A Securities, Reiterated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $53 to $63 on, Jul 13th, 2020.

Geoff has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Geoff's Rating of Hold.



This is the rating of the analyst that currently disagrees with Geoff


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $120 on, Wednesday, July 8th, 2020


Similar Stocks and Investing Publications